Hereditary nephropathy, not elsewhere classified with diffuse crescentic glomerulonephritis
ICD-10 N07.7 is a billable code used to indicate a diagnosis of hereditary nephropathy, not elsewhere classified with diffuse crescentic glomerulonephritis.
N07.7 refers to a specific type of hereditary nephropathy characterized by diffuse crescentic glomerulonephritis, a condition where the glomeruli in the kidneys become inflamed and form crescents, leading to significant renal impairment. This condition is often associated with genetic mutations that affect the structure and function of the kidney's filtration system. Patients may present with isolated proteinuria, which is the presence of excess protein in the urine, a common indicator of kidney dysfunction. The hereditary nature of this nephropathy suggests a familial pattern, often necessitating genetic testing to identify specific mutations. Diagnosis typically involves a combination of clinical evaluation, laboratory tests, and imaging studies, alongside a renal biopsy to confirm the presence of crescentic changes in the glomeruli. Management may include immunosuppressive therapy, supportive care, and monitoring for progression to end-stage renal disease. Understanding the genetic basis of this condition is crucial for family planning and risk assessment in affected families.
Detailed renal function tests, biopsy results, and genetic testing documentation.
Patients presenting with unexplained proteinuria, family history of kidney disease, or acute kidney injury.
Ensure that all genetic testing results are included in the medical record to support the hereditary diagnosis.
Comprehensive family history and results of genetic testing.
Patients referred for genetic counseling due to a family history of kidney disease.
Document the implications of genetic findings for family members.
Used to confirm diagnosis of crescentic glomerulonephritis.
Biopsy report must detail findings consistent with crescentic changes.
Nephrology specialists should ensure accurate reporting of biopsy results.
Genetic testing is crucial for confirming the hereditary nature of the nephropathy, guiding treatment decisions, and providing information for family members regarding their risk.
